Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitriol in COVID-19 Patients With Vitamin D Deficiency
NCT05415254Unknown
- Sponsor
- Renji Hospital
- Start
- Jun 2022
- Primary completion
- Aug 2022
- Countries
- 1
01
Overview
Randomised, open-label trial of calcitriol in coronavirus disease 2019 (COVID-19), sponsored by Renji Hospital. Primary endpoint: Cycle threshold value of COVID-19 nucleic acid at 6 days. Status: unknown.
02
Drugs
calcitriol
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05415254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05415254.